Nephros Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Nephros
NEPH Stock  USD 4.11  0.15  3.52%   
Nephros' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Nephros' valuation are provided below:
Gross Profit
11.3 M
Profit Margin
0.0826
Market Capitalization
43.7 M
Enterprise Value Revenue
2.3008
Revenue
17.9 M
We have found one hundred twenty available fundamental ratios for Nephros, which can be analyzed and compared to other ratios and to its peers in the industry. Traders should compare all of Nephros last-minute fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The Nephros' current Market Cap is estimated to increase to about 19.7 M. The Nephros' current Enterprise Value is estimated to increase to about 18.4 M

Nephros Total Revenue

17.1 Million

Check Nephros financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nephros' main balance sheet or income statement drivers, such as Depreciation And Amortization of 117.1 K, Interest Expense of 855 or Total Revenue of 17.1 M, as well as many indicators such as Price To Sales Ratio of 1.19, Dividend Yield of 0.0144 or PTB Ratio of 1.54. Nephros financial statements analysis is a perfect complement when working with Nephros Valuation or Volatility modules.
  
Build AI portfolio with Nephros Stock
Check out the analysis of Nephros Correlation against competitors.
For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.

Nephros Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets7.7 M12.9 M8.2 M
Slightly volatile
Other Current Liabilities408.4 K468.9 K389.8 K
Slightly volatile
Total Current Liabilities1.6 M1.4 M2 M
Slightly volatile
Accounts Payable703 K584.1 K922.4 K
Slightly volatile
Cash2.7 M4.3 M3 M
Slightly volatile
Other Assets59 K62.1 K536.4 K
Slightly volatile
Common Stock Shares Outstanding12.8 M12.2 M6.6 M
Slightly volatile
Other Current Assets198.2 K127.8 K179.5 K
Slightly volatile
Total Liabilities2.9 M2.4 M3.2 M
Pretty Stable
Preferred Stock Total Equity6.8 M8.3 M7.2 M
Slightly volatile
Common Stock25.1 K12.7 K22.7 K
Very volatile
Property Plant Equipment1.3 M1.3 M520 K
Slightly volatile
Short and Long Term Debt Total1.7 M1.6 M1.4 M
Slightly volatile
Property Plant And Equipment Net1.9 M1.8 M692.4 K
Slightly volatile
Non Current Assets Total1.8 M3.3 M2.2 M
Slightly volatile
Non Currrent Assets Other54.6 K57.5 K499.8 K
Slightly volatile
Cash And Short Term Investments3.7 M4.3 M3 M
Slightly volatile
Common Stock Total Equity10.9 K11.5 K21.8 K
Pretty Stable
Liabilities And Stockholders Equity8 M12.9 M8.2 M
Slightly volatile
Non Current Liabilities Total908.9 K956.7 K2.1 M
Slightly volatile
Other Stockholder Equity111.2 M175.8 M121.6 M
Slightly volatile
Property Plant And Equipment Gross3.1 M2.9 M972.4 K
Slightly volatile
Total Current Assets6.2 M9.5 M6 M
Slightly volatile
Short Term Debt697.4 K400.2 K681.4 K
Slightly volatile
Inventory3.2 M3 M1.8 M
Slightly volatile
Net Receivables2.2 M2 M1.1 M
Slightly volatile
Long Term Debt855900529.9 K
Slightly volatile
Other Liabilities224.9 K236.7 K1.2 M
Slightly volatile
Intangible Assets483.1 K508.5 K1.3 M
Slightly volatile
Capital Surpluse134.3 M165.9 M126.8 M
Slightly volatile
Deferred Long Term Liabilities250 K187.2 K283 K
Slightly volatile
Long Term Debt Total656.6 K761.4 K819.6 K
Slightly volatile
Short and Long Term Debt60.7 K63.9 K549.9 K
Slightly volatile
Net Invested Capital8.8 M9.9 M6.3 M
Slightly volatile
Net Working Capital8 M7.7 M5.2 M
Slightly volatile
Noncontrolling Interest In Consolidated Entity3.3 M3.5 M3.1 M
Slightly volatile
Good Will833.2 K872.9 K764.2 K
Slightly volatile
Capital Stock14.1 K9.9 K38.8 K
Slightly volatile
Capital Lease Obligations1.3 M1.6 M1.2 M
Slightly volatile

Nephros Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization117.1 K123.3 K225.7 K
Pretty Stable
Total Revenue17.1 M16.3 M7.2 M
Slightly volatile
Gross Profit10.5 M10 M4.2 M
Slightly volatile
Other Operating Expenses8.6 M16.3 M9.1 M
Slightly volatile
Research Development1.4 M1 M1.2 M
Slightly volatile
Cost Of Revenue6.6 M6.3 M3.1 M
Slightly volatile
Total Operating Expenses6.6 M10 M6.3 M
Slightly volatile
Selling General Administrative5.3 M8.8 M5.1 M
Slightly volatile
Interest Income80.4 K84.6 K746.6 K
Slightly volatile
Reconciled Depreciation156.4 K123.3 K198.2 K
Slightly volatile

Nephros Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow2.7 M4.3 M3 M
Slightly volatile
Begin Period Cash Flow2.7 M5 M2.8 M
Slightly volatile
Depreciation117.1 K123.3 K248.1 K
Slightly volatile
Dividends Paid186.4 K248.4 K213.7 K
Slightly volatile
Stock Based Compensation167.2 K175.9 K636.5 K
Pretty Stable
Change To Netincome1 M1.4 M1.2 M
Pretty Stable
Issuance Of Capital Stock6 M5.4 M4.6 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.191.266.4228
Slightly volatile
Dividend Yield0.01440.0110.0103
Very volatile
Days Sales Outstanding50.1552.7993.8852
Slightly volatile
Average Payables1.2 M1.2 M1.1 M
Pretty Stable
Stock Based Compensation To Revenue0.01180.01240.1484
Slightly volatile
Capex To Depreciation0.340.368.8349
Slightly volatile
EV To Sales1.011.0711.6417
Slightly volatile
Inventory Turnover2.352.392.2394
Slightly volatile
Days Of Inventory On Hand306202268
Pretty Stable
Payables Turnover7.927.544.0694
Slightly volatile
Sales General And Administrative To Revenue0.870.913.2675
Slightly volatile
Average Inventory464.6 K660.6 K695.8 K
Very volatile
Research And Ddevelopement To Revenue0.06990.07360.3836
Slightly volatile
Capex To Revenue0.00420.00450.4329
Slightly volatile
Cash Per Share0.390.412.0739
Slightly volatile
Days Payables Outstanding47.5850.09234
Slightly volatile
Intangibles To Total Assets0.130.140.3096
Slightly volatile
Current Ratio2.584.783.2822
Slightly volatile
Receivables Turnover5.037.166.5985
Pretty Stable
Graham Number0.290.320.3528
Slightly volatile
Capex Per Share0.00570.0060.2721
Slightly volatile
Average Receivables191.8 K337.2 K344.8 K
Very volatile
Revenue Per Share1.471.553.0463
Slightly volatile
Interest Debt Per Share0.150.134212.262
Slightly volatile
Debt To Assets0.290.140.2679
Slightly volatile
Operating Cycle405255364
Slightly volatile
Days Of Payables Outstanding47.5850.09234
Slightly volatile
Ebt Per Ebit14.0213.353.4061
Slightly volatile
Long Term Debt To Capitalization2.0E-42.0E-40.2457
Slightly volatile
Quick Ratio1.963.272.2982
Slightly volatile
Net Income Per E B T0.940.750.8098
Slightly volatile
Cash Ratio1.162.171.6261
Slightly volatile
Days Of Inventory Outstanding306202268
Pretty Stable
Days Of Sales Outstanding50.1552.7993.8852
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.171.281.0878
Pretty Stable
Fixed Asset Turnover7.878.2946.9861
Slightly volatile
Debt Ratio0.290.140.2679
Slightly volatile
Price Sales Ratio1.191.266.4228
Slightly volatile
Asset Turnover1.191.140.7346
Slightly volatile

Nephros Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap19.7 M13.9 M24.2 M
Pretty Stable
Enterprise Value18.4 M11.8 M22.4 M
Pretty Stable

Nephros Fundamental Market Drivers

Nephros Upcoming Events

13th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Nephros Financial Statements

Investors use fundamental indicators, such as Nephros' revenue or net income, to determine how well the company is positioned to perform in the future. Although Nephros' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue-1.1 M-1.1 M
Total Revenue16.3 M17.1 M
Cost Of Revenue6.3 M6.6 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.91  0.87 
Research And Ddevelopement To Revenue 0.07  0.07 
Revenue Per Share 1.55  1.47 

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether Nephros offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nephros' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nephros Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nephros Stock:
How To Invest In Nephros
Details
Is Nephros Stock a good investment?
Details
What is Nephros' Net Worth?
Details
Largest Household Appliances Companies
View
Largest Medical Instruments & Supplies Companies
View
Check out the analysis of Nephros Correlation against competitors.
For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is there potential for Household Appliances market expansion? Will Nephros introduce new products? Factors like these will boost the valuation of Nephros. Anticipated expansion of Nephros directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.729
Earnings Share
0.14
Revenue Per Share
1.693
Quarterly Revenue Growth
0.354
Return On Assets
0.0764
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Nephros' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nephros should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Nephros' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY